| Issue |
Section |
Title |
File |
| Vol 6, No 1 (2016) |
REVIEW |
Metronomic chemotherapy regimens in oncology |
 (Rus)
|
| Vol 6, No 2 (2016) |
ORIGINAL REPORTS |
Factors associated with the efficiency of maintenance therapy in patients with metastatic colorectal cancer |
 (Rus)
|
| Vol 7, No 1 (2017) |
ORIGINAL REPORTS |
Meta-analysis of clinical trials on concordance of mutational stauts of primary tumour and distant metastases of colorectal cancer |
 (Rus)
|
| Vol 7, No 3 (2017) |
ORIGINAL REPORTS |
Effect of cancer drugs in patients with metastatic colorectal cancer in terms of mortality reduction |
 (Rus)
|
| Vol 8, No 1 (2018) |
ORIGINAL REPORTS |
Efficacy of first-line oxaliplatin-based chemotherapy regimens depending on the KRAS mutation status |
 (Rus)
|
| Vol 8, No 2 (2018) |
ORIGINAL REPORTS |
Role of adjuvant chemotherapy in patients with rectal cancer after preoperative chemoradiotherapy: results of a retrospective study |
 (Rus)
|
| Vol 9, No 1 (2019) |
ORIGINAL REPORT |
Metastasectomy in patients with non-resectable metastatic colorectal cancer receiving chemotherapy and anti-EGFR antibodies: a prospective, non-randomized, multicenter, phase II study |
 (Rus)
|
| Vol 9, No 2 (2019) |
ORIGINAL REPORT |
Factors associated with efficacy of FOLFIRI/aflibercept in patients with metastatic colon cancer |
 (Rus)
|
| Vol 9, No 4 (2019) |
ORIGINAL REPORT |
FOLFOXIRI in patients with colon cancer and isolated non-resectable liver metastases: phase II prospective non-randomized single-center study |
 (Rus)
|
| Vol 12, No 3 (2022) |
ORIGINAL REPORT |
Personalized therapy in solid tumors: results of a retrospective multicentre study of the clinical applicability of the FoundationOne® Medicine Test |
 (Rus)
|
| Vol 14, No 2 (2024) |
ORIGINAL REPORT |
Efficacy and safety of different chemotherapy regimens in patients with disseminated pancreatic cancer over 65 years old |
 (Rus)
|
| Vol 14, No 4 (2024) |
ORIGINAL REPORT |
Prognostic and predictive factors in patients with metastatic gastric cancer treated with immune checkpoint inhibitors |
 (Rus)
|
| Vol 15, No 2 (2025) |
ORIGINAL REPORT |
Analysis of prognosis factors in patients with metastatic HER2‑positive gastric/cardioesophageal transition cancer treated in oncological clinics of Moscow |
 (Rus)
|